Silk Road Medical Inc (SILK)
17.65
+0.08
(+0.46%)
USD |
NASDAQ |
Apr 25, 16:00
17.66
+0.01
(+0.06%)
After-Hours: 20:00
Silk Road Medical Enterprise Value: 585.58M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 585.58M |
April 24, 2024 | 582.45M |
April 23, 2024 | 586.37M |
April 22, 2024 | 576.18M |
April 19, 2024 | 572.66M |
April 18, 2024 | 576.57M |
April 17, 2024 | 578.14M |
April 16, 2024 | 587.93M |
April 15, 2024 | 601.25M |
April 12, 2024 | 607.13M |
April 11, 2024 | 643.17M |
April 10, 2024 | 608.70M |
April 09, 2024 | 608.70M |
April 08, 2024 | 580.88M |
April 05, 2024 | 588.72M |
April 04, 2024 | 558.16M |
April 03, 2024 | 589.50M |
April 02, 2024 | 576.97M |
April 01, 2024 | 584.80M |
March 28, 2024 | 611.83M |
March 27, 2024 | 627.11M |
March 26, 2024 | 639.64M |
March 25, 2024 | 616.14M |
March 22, 2024 | 623.58M |
March 21, 2024 | 634.16M |
Date | Value |
---|---|
March 20, 2024 | 637.29M |
March 19, 2024 | 615.75M |
March 18, 2024 | 559.73M |
March 15, 2024 | 515.07M |
March 14, 2024 | 509.19M |
March 13, 2024 | 500.57M |
March 12, 2024 | 516.24M |
March 11, 2024 | 520.95M |
March 08, 2024 | 536.62M |
March 07, 2024 | 520.16M |
March 06, 2024 | 507.23M |
March 05, 2024 | 555.42M |
March 04, 2024 | 589.50M |
March 01, 2024 | 566.78M |
February 29, 2024 | 598.90M |
February 28, 2024 | 587.15M |
February 27, 2024 | 579.32M |
February 26, 2024 | 576.18M |
February 23, 2024 | 560.12M |
February 22, 2024 | 571.32M |
February 21, 2024 | 569.37M |
February 20, 2024 | 565.84M |
February 16, 2024 | 608.92M |
February 15, 2024 | 580.14M |
February 14, 2024 | 537.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
127.23M
Minimum
Oct 25 2023
2.266B
Maximum
Nov 06 2020
1.327B
Average
1.375B
Median
Sep 01 2022
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 931.55M |
Retractable Technologies Inc | -13.79M |
Xtant Medical Holdings Inc | 133.46M |
Asensus Surgical Inc | 44.48M |
Catheter Precision Inc | 0.7844M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -13.01M |
Revenue (Quarterly) | 47.27M |
Total Expenses (Quarterly) | 61.64M |
EPS Diluted (Quarterly) | -0.34 |
Gross Profit Margin (Quarterly) | 73.62% |
Profit Margin (Quarterly) | -27.52% |
Earnings Yield | -8.22% |
Normalized Earnings Yield | -8.215 |